Partial volume correction strategies for quantitative FDG PET in oncology.
about
Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging.Can Initial (18)F-FDG PET-CT Imaging Give Information on Metastasis in Patients with Primary Renal Cell Carcinoma?Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studiesDesign considerations for using PET as a response measure in single site and multicenter clinical trials.Optimising delineation accuracy of tumours in PET for radiotherapy planning using blind deconvolution.Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.(124)I-huA33 antibody PET of colorectal cancer.Can Parameters Other than Minimal Axial Diameter in MRI and PET/CT Further Improve Diagnostic Accuracy for Equivocal Retropharyngeal Lymph Nodes in Nasopharyngeal Carcinoma?Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.Evaluation of a 3D local multiresolution algorithm for the correction of partial volume effects in positron emission tomography.A method for model-free partial volume correction in oncological PET.Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy.Genotyping analysis and ¹⁸FDG uptake in breast cancer patients: a preliminary research.Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.Tumor quantification in clinical positron emission tomography.Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapyAnatomical-based partial volume correction for low-dose dedicated cardiac SPECT/CT.Prognostic value of 18F-FDG uptake by regional lymph nodes on pretreatment PET/CT in patients with resectable colorectal cancer.PET in the management of locally advanced and metastatic NSCLC.Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.Failed PET Application Attempts in the Past, Can We Avoid Them in the Future?Validation of phantom-based harmonization for patient harmonization.Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising.Image-derived and arterial blood sampled input functions for quantitative PET imaging of the angiotensin II subtype 1 receptor in the kidney.Noise suppressed partial volume correction for cardiac SPECT/CT.INVESTIGATION OF PARTIAL VOLUME EFFECT IN DIFFERENT PET/CT SYSTEMS: A COMPARISON OF RESULTS USING THE MADEIRA PHANTOM AND THE NEMA NU-2 2001 PHANTOM.Anatomy assisted PET image reconstruction incorporating multi-resolution joint entropy.Impact of the point spread function on maximum standardized uptake value measurements in patients with pulmonary cancer.Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.Point/counterpoint. Resolution modeling enhances PET imaging.The use of zeolites to generate PET phantoms for the validation of quantification strategies in oncology.Transconvolution and the virtual positron emission tomograph--a new method for cross calibration in quantitative PET∕CT imaging.Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction.Recovery coefficients determination for partial volume effect correction in oncological PET/CT images considering the effect of activity outside the field of view.Isotope independent determination of PET/CT modulation transfer functions from phantom measurements on spheres.SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions.Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer.
P2860
Q30250349-D778939C-FC54-4C59-AA31-486968DA40BAQ30407270-0ABE8D37-FCC0-4202-BF92-429D6D8D3BD1Q33639383-EF690BD7-B097-4C25-9E8C-42F7FBFCAE0AQ34175770-3EC696FD-D829-477F-AC37-B1DC2A577989Q35151263-9AC01326-8EF4-4C47-B8E8-72574560C1ACQ35653277-9046D77E-A19B-4230-BB31-914A91979D39Q35849051-75D388BF-9281-4623-82F9-1045EE8A5D57Q35861064-1B027BCD-485B-484D-932C-AFC41AF75511Q36088144-05336C96-8876-48DC-8B35-AB78DFC1B85AQ36162670-38402B7E-37EB-4FB5-8371-0D55E9469687Q36335078-3BAB3429-795E-47B4-81B2-69ECDF40198CQ36360240-A8D24A7E-9783-46A1-B732-1BA74A5B7807Q36411892-5F07BDA0-245B-4BA4-9465-CDEAEC293472Q36508524-F402F58D-7D81-467D-8A8E-7C829F3C2432Q36823340-F43B8AB7-477E-4732-BC70-343E4298F418Q37230607-220D26EE-6624-4844-8A1E-8A487D4FA6C0Q37342658-563A9DF8-4835-4015-90BC-AE33C3EED15CQ38243086-FA5B4554-E3D7-4154-8CCC-69503304F0F3Q38309781-C73E0625-856A-4385-A9C3-21A24D289FA3Q38436640-BA43A7BE-21C2-4553-B65D-698D8643B941Q38444980-9685AA0E-FE43-4FD5-A5F8-A044D93EA7DBQ38641832-65DA25A8-DF52-4430-BA0C-6ED8DF5046A3Q38800009-EBEA7F70-3486-402C-AA94-380DB0A48BCBQ38808641-51A04F03-C0C9-4724-BF60-204F8E607270Q38825502-87D080AC-0C2D-4122-8238-87E6C0409FCFQ38947793-63E94A3D-8763-4C65-A0DF-C40661EDB829Q39430044-AD628AD2-A2A1-4474-B7FA-175B920C2A55Q39949795-1692CBFB-C971-4E5A-A9BC-4C26AC15DD47Q41475934-E4080812-1A53-4C92-99F0-5B3D4903F5EEQ42069874-0FAA61F5-A38D-436F-924F-0D2147987E78Q43919851-3723C3BE-B360-4EF1-A004-EA698115BB89Q44029390-7D6B48BF-BBCF-4DA9-B45A-FA85A346A6DEQ45276235-835BB957-1AD5-4B3D-B41D-9F927C351AA4Q46108039-CE4CA145-3507-4C42-A5A9-980742D90B4CQ47699328-7E6E6E94-4CF2-4CD2-BC71-ACB58C36EB37Q48419621-39352900-C9BF-481F-8B6D-3FA2F16E9715Q48922888-12BE2AA1-8C64-4AEC-BDB9-B0BFBC8CDE2CQ50560061-53D35197-988C-4208-9223-8918C1EFC427Q50878255-7EEFA46B-A0E4-4B4F-9007-CB51580CF3BAQ53161923-5C124DEA-8DD6-4497-B2B7-17B2178B3104
P2860
Partial volume correction strategies for quantitative FDG PET in oncology.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Partial volume correction strategies for quantitative FDG PET in oncology.
@ast
Partial volume correction strategies for quantitative FDG PET in oncology.
@en
Partial volume correction strategies for quantitative FDG PET in oncology.
@nl
type
label
Partial volume correction strategies for quantitative FDG PET in oncology.
@ast
Partial volume correction strategies for quantitative FDG PET in oncology.
@en
Partial volume correction strategies for quantitative FDG PET in oncology.
@nl
prefLabel
Partial volume correction strategies for quantitative FDG PET in oncology.
@ast
Partial volume correction strategies for quantitative FDG PET in oncology.
@en
Partial volume correction strategies for quantitative FDG PET in oncology.
@nl
P2093
P2860
P1476
Partial volume correction strategies for quantitative FDG PET in oncology.
@en
P2093
Corneline J Hoekstra
Floris H P van Velden
Nanda C Krak
Nikie J Hoetjes
Otto S Hoekstra
P2860
P2888
P304
P356
10.1007/S00259-010-1472-7
P577
2010-04-27T00:00:00Z